Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Emma Walmsley

    - PMLiVE

    AXON NAMES NEW PRESIDENT AND MANAGING PARTNER, TINA HAHN, AS RALPH SUTTON CHANGES LANE

    April 30, 2025—Tina Hahn, who joined AXON in 2012 as Vice President, will now take on the role of AXON’s President and Managing Partner.

    AXON

    Accession Logo

    Accession announces major UK market access consulting milestone

    February 5th 2025: Today Accession Healthcare Consulting Ltd (Accession) has announced the achievement of a major consulting milestone as it enters its 15th year as a specialist provider of UK...

    Accession

    - PMLiVE

    CureVac advances ‘promising’ seasonal flu mRNA vaccine to phase 2 development

    The mid-stage study of the candidate is expected to begin in the fourth quarter of 2023

    - PMLiVE

    Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

    The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

    Innovative Trials

    - PMLiVE

    Onyx Health Expands with Two New Appointments

    Newcastle-based creative agency Onyx Health has continued to grow and expand with the dual appointments of Rosie Thompson as Account Manager and Modupe Ayeni as a Medical Writer

    Onyx Health

    - PMLiVE

    Onyx Health Expands with Two New Digital Appointments

    Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.

    Onyx Health

    - PMLiVE

    FDA approves GSK’s Priorix vaccine for measles, mumps and rubella

    The vaccine has been approved to use in those aged 12 months and above

    - PMLiVE

    Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn

    Unification will help to uphold and progress promising Momelotinib treatment which targets myelofibrosis

    - PMLiVE

    GSK and CureVac sign deal with Germany for mRNA COVID-19 vaccines

    The agreement is part of a Pandemic Preparedness Contract and means millions of vaccines can be produced at short notice during future public health emergencies

    Onyx Health Announces a “Double Hatrick” of New Appointments

    Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

    Onyx Health

    - PMLiVE

    Onyx Health Announces Two Top Appointments

    Onyx health have made two senior appointments to their communications team

    Onyx Health

    dengue fever mosquito

    WHO has recommended GSK’s malaria vaccine for children

    This is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links